Tri-Moxi intraocular injection recalled over glass-like particulate matter
Imprimis NJOF is recalling 314 boxes containing 6,280 pre-filled syringes of Tri-Moxi triamcinolone and moxifloxacin intraocular injection over glass-like particles.
- Product
- Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
- Category
- Drug
- Distribution
- Distributed nationwide